Research workbench

Crystal structure of human tob in complex with inhibitor fragment 6

Analyse Crystal structure of human tob in complex with inhibitor fragment 6 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB: 5CI9
Type: protein
Length: 116 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Protein TOB1
UniProt: P50616
Ligands: 549, NA

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 19% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Protein TOB1	protein	116	44% helix, 19% strand	P50616

Ligands and binding sites

549 · 1-(propan-2-yl)-1H-benzimidazole-5-carboxylic acid · ligand · 2 copies · chains A
NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

5CI9 · Crystal structure of human Tob in complex with inhibitor fragment 6 · the same entry in another collection · chain A against A, TM-score 1.00
P50616 · AlphaFold monomer V2.0 prediction for protein TOB1 (P50616) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P50616
Elsewhere: RCSB PDB 5CI9 · PDBe 5CI9 · UniProt P50616

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.